| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.
|
BMJ
|
2011
|
2.50
|
|
2
|
Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication.
|
PLoS One
|
2012
|
2.21
|
|
3
|
Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
|
J Infect Dis
|
2014
|
1.23
|
|
4
|
Evaluation and verification of the Seeplex Diarrhea-V ACE assay for simultaneous detection of adenovirus, rotavirus, and norovirus genogroups I and II in clinical stool specimens.
|
J Clin Microbiol
|
2011
|
1.11
|
|
5
|
Rhinovirus outbreaks in long-term care facilities, Ontario, Canada.
|
Emerg Infect Dis
|
2010
|
1.02
|
|
6
|
Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.
|
Emerg Infect Dis
|
2013
|
0.98
|
|
7
|
Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.
|
Euro Surveill
|
2016
|
0.98
|
|
8
|
Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.
|
Clin Infect Dis
|
2013
|
0.98
|
|
9
|
Severe human rhinovirus outbreak associated with fatalities in a long-term care facility in Ontario, Canada.
|
J Am Geriatr Soc
|
2010
|
0.96
|
|
10
|
Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
|
PLoS One
|
2011
|
0.95
|
|
11
|
Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child.
|
Emerg Infect Dis
|
2011
|
0.94
|
|
12
|
Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.
|
J Clin Virol
|
2010
|
0.94
|
|
13
|
Community-acquired respiratory viruses and co-infection among patients of Ontario sentinel practices, April 2009 to February 2010.
|
Influenza Other Respir Viruses
|
2012
|
0.90
|
|
14
|
Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses.
|
Euro Surveill
|
2016
|
0.88
|
|
15
|
Have changing pneumococcal vaccination programmes impacted disease in Ontario?
|
Vaccine
|
2013
|
0.86
|
|
16
|
Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.
|
Influenza Other Respir Viruses
|
2013
|
0.86
|
|
17
|
Respiratory infection in institutions during early stages of pandemic (H1N1) 2009, Canada.
|
Emerg Infect Dis
|
2009
|
0.86
|
|
18
|
T cell memory to evolutionarily conserved and shared hemagglutinin epitopes of H1N1 viruses: a pilot scale study.
|
BMC Infect Dis
|
2013
|
0.83
|
|
19
|
Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
|
J Infect Dis
|
2017
|
0.82
|
|
20
|
Human metapneumovirus prevalence and molecular epidemiology in respiratory outbreaks in Ontario, Canada.
|
J Med Virol
|
2014
|
0.82
|
|
21
|
High prevalence of asymptomatic bocavirus in daycare: is otitis media a confounder?
|
J Infect Dis
|
2010
|
0.81
|
|
22
|
Respiratory viral infections in institutions from late stage of the first and second waves of pandemic influenza A (H1N1) 2009, Ontario, Canada.
|
Influenza Other Respir Viruses
|
2012
|
0.81
|
|
23
|
Temporal changes in respiratory adenovirus serotypes circulating in the greater Toronto area, Ontario, during December 2008 to April 2010.
|
Virol J
|
2013
|
0.80
|
|
24
|
Potential T cell epitopes within swine-origin triple reassortant influenza A (H3N2) variant virus which emerged in 2011: an immunoinformatics study.
|
Vaccine
|
2012
|
0.80
|
|
25
|
Detection of an influenza B virus strain with reduced susceptibility to neuraminidase inhibitor drugs.
|
J Clin Microbiol
|
2011
|
0.79
|
|
26
|
Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.
|
J Clin Microbiol
|
2012
|
0.78
|
|
27
|
Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007-2012.
|
Pediatr Infect Dis J
|
2015
|
0.77
|
|
28
|
Local public health response to vaccine-associated measles: case report.
|
BMC Public Health
|
2013
|
0.77
|
|
29
|
Acute Respiratory Infections in Travelers Returning from MERS-CoV-Affected Areas.
|
Emerg Infect Dis
|
2015
|
0.75
|
|
30
|
Spectrum of Viral Pathogens in Blood of Malaria-Free Ill Travelers Returning to Canada.
|
Emerg Infect Dis
|
2016
|
0.75
|
|
31
|
Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015.
|
Emerg Infect Dis
|
2017
|
0.75
|
|
32
|
Expression of recombinant HA1 protein for specific detection of influenza A/H1N1/2009 antibodies in human serum.
|
Microbiol Immunol
|
2013
|
0.75
|
|
33
|
Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.
|
Infect Control Hosp Epidemiol
|
2013
|
0.75
|
|
34
|
Transmission of influenza A pandemic (H1N1) 2009 virus in a long-term care facility in Ontario, Canada.
|
Infect Control Hosp Epidemiol
|
2010
|
0.75
|